ISO-690 (author-date, English)

HOLMES, Emily A.F., PLUMPTON, Catrin, BAKER, Gus A., JACOBY, Ann, RING, Adele, WILLIAMSON, Paula, MARSON, Anthony und HUGHES, Dyfrig A., 2019. Patient-focused drug development methods for benefit-risk assessments:A case study using discrete choice experiment for antiepileptic drugs. $2. 1 Januar 2019.

Elsevier - Harvard (with titles)

Holmes, E.A., Plumpton, C., Baker, G.A., Jacoby, A., Ring, A., Williamson, P., Marson, A., Hughes, D.A., 2019. Patient-focused drug development methods for benefit-risk assessments:A case study using discrete choice experiment for antiepileptic drugs. $2.

American Psychological Association 7th edition

Holmes, E. A., Plumpton, C., Baker, G. A., Jacoby, A., Ring, A., Williamson, P., Marson, A., & Hughes, D. A. (2019). Patient-focused drug development methods for benefit-risk assessments:A case study using discrete choice experiment for antiepileptic drugs. $2.

Springer - Basic (author-date)

Holmes EA, Plumpton C, Baker GA, Jacoby A, Ring A, Williamson P, Marson A, Hughes DA (2019) Patient-focused drug development methods for benefit-risk assessments:A case study using discrete choice experiment for antiepileptic drugs. $2

Juristische Zitierweise (Stüber) (Deutsch)

Holmes, Emily A.F./ Plumpton, Catrin/ Baker, Gus A./ Jacoby, Ann/ Ring, Adele/ Williamson, Paula/ Marson, Anthony/ Hughes, Dyfrig A., Patient-focused drug development methods for benefit-risk assessments:A case study using discrete choice experiment for antiepileptic drugs, $2 2019.

Bitte prüfen Sie die Zitate auf Korrektheit, bevor Sie diese in Ihre Arbeit einfügen.